As the miracle drug cure for cancer Keytruda nears expiry almost seven Indian manufacturers are set on a race to develop generic versions of the drug.
Cashless healthcare is set to transform the lives of thousands of workers in the national capital after the Delhi Cabinet approved a new healthcare scheme worth Rs 200 crore annually.
India’s drugmakers see limited gains from the minimum import price policy as weak demand, stockpiling, and slow buyer shifts delay the impact on domestic pharma manufacturing.
The Shigella threat in Kerala continues to grow as the state reported one more death linked to the infection along with seven fresh cases from multiple districts.
.jpeg)
India’s generic cancer drug market is expanding with improved affordability, innovation, and access, as companies like Alembic advance complex oncology generics globally.
Gujarat’s Sickle Cell Mission has emerged as one of India’s most successful public health initiatives, with the state crossing 1.11 crore screenings for sickle cell disease.
Midjourney, the AI image-generation startup known for creating digital art, is making an unexpected move into healthcare.
Glenmark's drug launch could be a game changer as it expands its presence in the high-value rare disease segment.
The bowel disease treatment race is gaining momentum after Spyre Therapeutics reported positive results from a mid-stage clinical trial of its experimental ulcerative colitis drug, SPY002.
.jpeg)
A copper-based drug shows potential in reducing toxic proteins and improving cognition in Alzheimer’s, offering a new approach targeting brain waste clearance mechanisms.
.jpg)
, CDSCO.jpg)